Pet Education Cats
Pet Education Cats Pet Education Cats Pet Education Cats

Learn about Vetco
Dog Food Cat Food New Brands - Healthy Choices Just Added!
Free Shipping on orders over $49
Video Center
Cyclosporine-Oral (Sandimmune®, Neoral®, Atopica®)
Veterinary & Aquatic Services Department, Drs. Foster & Smith
Ear & Skin
Print Article | Email Article
Bookmark and Share
Click here for a pdf version of this article. 
click here for drug information 

Cyclosporine suppresses the immune system and is used to treat immune-mediated diseases, especially those involving the blood or skin. It may also be used in the treatment of anal fistulas in dogs, asthma in cats, and to prevent rejection of transplanted organs. One brand, Atopica, is approved for use to treat atopy (allergy to inhaled substances). Contact your veterinarian if your pet experiences loss of appetite, vomiting, diarrhea, overgrowth of the gums, muscle cramps, increased hair growth, increased thirst, increased urination, jaundice (yellowing of gums, skin, or whites of the eyes), or lethargy while being treated with cyclosporine.


Keep this and all other medications out of the reach of children and pets.


If you think your pet has been poisoned...

Contact your veterinarian or one of the Animal Poison Hotlines (listed below) if you think your pet may have accidentally received or been given an overdose of the medication.

**ASPCA Animal Poison Control Center - 24-hour service available throughout North America.
www.aspca.org/apcc

1-888-4ANI-HELP (1-888-426-4435). $65.00 per case, billed to caller's credit card.

Follow-up calls can be made for no additional charge by dialing 888-299-2973.

There is no charge when the call involves a product covered by the Animal Product Safety Service.

**Pet Poison Helpline - 24-hour service available throughout North America for pet owners and veterinary professionals who require assistance with treating a potentially poisoned pet.

1-800-213-6680 ($59.00 per incident). Staffed 24-hours a day.

Updated 6/20/17


Click here for a pdf version of this article.   
Print Article | Email Article